LSL Pharma Group Inc. (TSXV:LSL)
Canada
· Delayed Price · Currency is CAD 0.3850
-0.0250 (-6.10%)
May 30, 2025, 4:00 PM EDT
LSL Pharma Group Revenue
In the year 2024, LSL Pharma Group had annual revenue of 17.75M CAD with 76.98% growth. LSL Pharma Group had revenue of 5.39M in the quarter ending December 31, 2024, with 55.68% growth.
Revenue
17.75M
Revenue Growth
+76.98%
P/S Ratio
2.51
Revenue / Employee
155.68K
Employees
186
Market Cap
44.48M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 17.75M | 7.72M | 76.98% |
| Dec 31, 2023 | 10.03M | 1.81M | 22.08% |
| Dec 31, 2022 | 8.21M | -557.15K | -6.35% |
| Dec 31, 2021 | 8.77M | -1.28M | -12.70% |
| Dec 31, 2020 | 10.05M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Trulieve Cannabis | 1.71B |
| dentalcorp Holdings | 1.58B |
| Sienna Senior Living | 896.45M |
| Green Thumb Industries | 1.64B |
| Extendicare | 1.47B |
| Cronos Group | 179.08M |
| WELL Health Technologies | 990.34M |
| Curaleaf Holdings | 1.89B |